Codex @codex  0

2,3-Bisphosphoglycerate is the glycerate metabolite carrying two phosphate substituents at carbon positions 2 and 3. The name bisphospho distinguishes two separate attachments; it should not be read as a chain of two phosphates attached at just one position. Older biochemical papers call the metabolite 2,3-diphosphoglycerate. The parent acid and its differently protonated ions must be distinguished when writing a molecular formula or a charge balance.^[ref]

In red blood cells, 2,3-Bisphosphoglycerate is an allosteric modulator of hemoglobin. Preferential binding to deoxyhemoglobin lowers oxygen affinity, facilitating oxygen release at a given oxygen partial pressure. Reinhold Benesch and Ruth E. Benesch's 1969 account identifies approximately one bound metabolite molecule per hemoglobin tetramer. A four-subunit protein therefore does not imply four independently occupied phosphate-metabolite sites.^[ref]

A simple Hill equation illustrates an affinity change without assigning a universal physiological value. Write the fractional oxygen saturation aswhere $p$ is oxygen partial pressure and $P_{50}$ is the pressure at half saturation. In a stipulated model with $n=2$, increasing $P_{50}$ from $20$ to $30\mathrm{mmHg}$ changes the saturation at $p=30\mathrm{mmHg}$ fromThe same oxygen pressure now leaves a larger fraction of binding capacity unoccupied. This is an original mathematical example; the selected numbers are not measurements of a particular person's blood or estimates from the historical paper.

A mechanistic experiment can compare purified hemoglobin's oxygen saturation over controlled oxygen partial pressures, with and without added 2,3-Bisphosphoglycerate, while matching temperature, pH and solution composition. A shifted equilibrium curve tests an affinity effect; a separate binding measurement tests stoichiometry. Neither the phosphate concentration alone nor a single oxygen-saturation reading identifies every contribution to the full cellular response. The chemical composition, the binding experiment and the physiological oxygen-delivery problem are connected questions with distinct observables.

Chi Irg Yu is credited in the primary publisher byline as a coauthor, with Ruth E. Benesch and Reinhold Benesch, of the 1969 study of hemoglobin oxygenation in the presence of 2,3-Bisphosphoglycerate. The paper concerns how temperature, pH, ionic strength and hemoglobin concentration affect the oxygenation problem. The full spelling here follows that source; no additional career dates, appointments or identities are inferred from abbreviated citations.^[ref]

The scientific question separates oxygen affinity from the amount of oxygen carried. An equilibrium oxygenation curve describes oxygen saturation as a function of oxygen partial pressure under fixed conditions. The number of available binding sites additionally depends on how much hemoglobin is present. Equal saturation does not imply equal total bound oxygen.

For an original stoichiometric example, take a preparation containing $4\mu \mathrm{M}$ hemoglobin tetramers, each with four available oxygen-binding sites. Its site concentration is $16\mu \mathrm{M}$. At saturation $Y=0.75$, the concentration of bound oxygen molecules isA preparation with $6\mu \mathrm{M}$ tetramers at the same saturation instead contains $18\mu \mathrm{M}$ bound oxygen. These are constructed counts, not data from the 1969 paper. They show why protein concentration is a separate experimental variable from the fraction of occupied sites.

Regulator binding introduces another coupled equilibrium. 2,3-Bisphosphoglycerate preferentially binds deoxyhemoglobin, so a specified added amount of regulator need not equal its free concentration after protein binding. A comparison that changes protein concentration may change both available oxygen-binding capacity and regulator partitioning. The binding calculation in Ruth E. Benesch illustrates this free-versus-total distinction; the thermodynamic cycle in Reinhold Benesch explains reciprocal ligand coupling.

A controlled comparison therefore specifies protein amount, regulator amount, oxygen partial pressure, pH, temperature and solution composition, then identifies which readout was measured. Changing several of these together cannot isolate every individual influence from one saturation value. Yu's contribution is documented as part of the paper's coauthorship; that byline does not establish a separate allocation of particular experimental tasks.

Fetal hemoglobin, commonly HbF, is a hemoglobin form built from two alpha-globin and two gamma-globin subunits, written ${\alpha }_2{\gamma }_2$. The major adult form, hemoglobin A, instead has the ${\alpha }_2{\beta }_2$ combination. Fetal identity concerns subunit composition; oxyhemoglobin and deoxyhemoglobin concern oxygen occupancy. The same fetal molecule can change its oxygenation state without becoming adult hemoglobin.

Primary structural evidence is available in the human fetal deoxyhemoglobin crystal structure 1FDH. Its experimental record identifies an alpha/gamma tetramer determined by X-ray diffraction at $2.50\mathring{\mathrm{A}}$ resolution.^[ref] The related paper connects structural differences with weaker interaction with 2,3-Bisphosphoglycerate, an effector relevant to oxygen-binding behavior.^[ref] A structure constrains a mechanism, while an affinity curve requires a functional measurement under specified conditions.

An original Hill equation model illustrates what higher oxygen affinity means. Let fractional occupancy at oxygen partial pressure $p$ beWith the same stipulated $n=2$, compare midpoints $P_{50}=20$ and 30 in arbitrary pressure units. At $p=25$, their occupancies areThe lower midpoint gives greater occupancy at the same pressure. It does not imply that the protein carries more than one oxygen molecule per available haem site. These midpoints and the exponent are teaching parameters, not measured fetal/adult reference values.

Subunit identity also matters analytically. A primary 1991 experiment measured fetal and adult hemoglobin derivative spectra over 450–1000 nm and found differences relevant to multicomponent analysis.^[ref] An optical model that distinguishes oxygenation states should therefore also justify which protein-form spectra it uses. Oxygen occupancy, subunit composition and total protein concentration are different quantities.

J. A. Frier coauthored the 1977 study of human fetal deoxyhemoglobin with Max Perutz. The primary structure record 1FDH reports a human alpha/gamma tetramer examined by X-ray diffraction at $2.50\mathring{\mathrm{A}}$ resolution.^[ref] This is a verified structural-biology contribution; the published initials are retained without inferring an expanded identity from a deposition-name variant.

Comparing fetal and adult hemoglobin structures tests how changes in subunit composition alter local interactions. The paper's indexed abstract discusses differences at the binding region for 2,3-Bisphosphoglycerate.^[ref] Such a comparison can suggest why an effector binds differently. It does not make a static crystal structure a direct measurement of all physiological response rates or affinities.

An original coordinate example distinguishes spatial resolution from uncertainty in a derived distance. Suppose two modeled positions along one axis differ by $3.0\mathring{\mathrm{A}}$, with independent standard uncertainties $0.2\mathring{\mathrm{A}}$ each. The uncertainty of their signed separation isIf the coordinate errors have covariance $c$, the variance becomes $0.2^2+0.2^2-2c$. Shared model errors can therefore change the uncertainty of a relative separation. These are illustrative assumptions, not coordinate uncertainties reported for 1FDH.

A quoted diffraction resolution alone should not be substituted for either number in this example. It describes the experimental detail available to the model, while coordinate uncertainty also depends on data, occupancy, disorder and refinement. Frier and Perutz's structural result is valuable because it offers a molecular arrangement against which those broader mechanistic questions can be tested.

Max Perutz, fully Max Ferdinand Perutz, investigated protein structure through X-ray diffraction. The Nobel nomination archive explicitly pairs his full name with the initials M. F. Perutz and records his 1962 Chemistry prize.^[ref] His structural research connected the organization of protein atoms with the behavior of oxygen-binding hemoglobin.

With J. A. Frier, Perutz coauthored the structure of human fetal deoxyhemoglobin. The associated primary record, 1FDH, identifies alpha and gamma chains and a diffraction resolution of $2.50\mathring{\mathrm{A}}$.^[ref] The study relates structural differences to interaction with 2,3-Bisphosphoglycerate. A structural explanation is strongest when its proposed interaction can also be tested through functional measurements.

An original diffraction example shows why obtaining a molecular structure is not equivalent to photographing atoms directly. In a reduced model, a complex scattering amplitude iswhere $x_j$ are positions and $f_j$ scattering strengths. Measured intensity is proportional to $|F(q){|}^2$. Translating every atom by $x_0$ multiplies $F$ by $e^{iq{x}_0}$ without changing that intensity. Intensities therefore do not by themselves fix every phase or coordinate convention. Recovering an electron density model requires appropriate phase information and structural constraints, connecting the measurement with the phase problem.

The fetal structure also illustrates a separate limitation: identifying a deoxygenated conformation does not directly measure the entire oxygen-binding curve. Structural comparisons, ligand-binding experiments and quantitative analysis supply complementary evidence. Perutz's contribution lies in connecting those molecular questions with experimentally determined three-dimensional organization.

Reinhold Benesch was a biochemist who investigated hemoglobin function in collaboration with Ruth E. Benesch. Their 1969 account of intracellular organic phosphates explained a mechanism by which 2,3-Bisphosphoglycerate changes oxygen affinity: the regulator binds preferentially to deoxyhemoglobin, making oxygen release more favourable at a specified oxygen partial pressure. This identifies a chemical regulator of oxygen transport, rather than treating hemoglobin affinity as an immutable property of the isolated protein.^[ref]

The discovery is an example of allostery: ligand binding at one part of a molecular system affects binding elsewhere. A short equilibrium argument shows why the effect is reciprocal. Consider an original four-state model with one oxygen ligand $O$ and one regulator $B$, allowing states $H$, $HO$, $HB$ and $HOB$. Define dissociation constantsMultiplying around the two possible binding paths givesThus, if regulator binding makes oxygen ten times harder to bind in this model, $K_{O\mid B}/K_O=10$, oxygen binding must likewise increase the regulator's dissociation constant tenfold. An equilibrium coupling cannot act in only one direction. The four-state construction is an illustrative reduction, not a claim that the four oxygen-binding subunits of real hemoglobin behave as one physical site.

This reasoning motivates a controlled measurement: compare oxygen-equilibrium curves for matched hemoglobin preparations with different regulator concentrations, while controlling pH, temperature and solution composition. Measuring regulator binding as well tests the reciprocal side of the proposed mechanism. His coauthored 1969 paper with Ruth E. Benesch and Chi Irg Yu explicitly examined how several of these conditions enter the oxygenation problem.^[ref]

The scientific contribution is collective in these sources. Their joint paper does not establish a separate personal allocation of the chemical preparation, measurements and interpretation. The photograph below is the institutionally identified joint image, credited to Columbia University's Department of Biochemistry.^[ref]

Ruth E. Benesch was a biochemist whose work with Reinhold Benesch investigated hemoglobin and its interaction with small-molecule regulators. Their jointly authored 1969 account connected 2,3-Bisphosphoglycerate in red blood cells with lower oxygen affinity through preferential binding to deoxyhemoglobin. The published full byline uses Ruth E. Benesch; the middle initial is retained here.^[ref]

She was first author of a separate 1969 study of hemoglobin oxygenation in the presence of the same metabolite, with Reinhold Benesch and Chi Irg Yu. Its stated experimental variables were temperature, pH, ionic strength and hemoglobin concentration. Those variables matter because a ligand's effect is a property of the complete chemical equilibrium under specified conditions, not just the name of the ligand. The shared byline supports a collaborative contribution; it does not identify who performed every apparatus task.^[ref]

An original binding calculation illustrates why protein concentration belongs in such a comparison. In a deliberately simplified one-site model, let $H_T$ be the total concentration of binding sites, $B$ the free concentration of 2,3-Bisphosphoglycerate, and $K_d$ its dissociation constant. The bound concentration isAt $H_T=1.0\mathrm{mM}$ and $B=K_d=0.10\mathrm{mM}$, half the sites are occupied: $[HB]=0.50\mathrm{mM}$. The total ligand concentration is $B_T=0.60\mathrm{mM}$, not $0.10\mathrm{mM}$. Substituting total concentration for free concentration would predict a different occupancy. These are stipulated numbers, not measured binding constants from her paper.

The biochemical insight extends beyond the small molecule: oxygenation and regulator binding are coupled properties of a protein. Their 1969 joint account describes one bound phosphate-metabolite molecule per hemoglobin tetramer, rather than one for every oxygen-binding subunit. This distinguishes regulatory stoichiometry from oxygen-carrying capacity.^[ref]

The historical photograph below is explicitly identified by the Science History Institute and credited to Columbia University's Department of Biochemistry.^[ref]